Overview

Social Anxiety Disorder Study Of Paroxetine

Status:
Completed
Trial end date:
2006-11-01
Target enrollment:
Participant gender:
Summary
This study is designed to evaluate the efficacy and safety in Social Anxiety Disorder (SAD).
Phase:
Phase 3
Details
Lead Sponsor:
GlaxoSmithKline
Treatments:
Paroxetine